Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilaprisan dose-finding study in healthy women
NCT02262663Phase 1Completed
- Sponsor
- Bayer
- Start
- Oct 2014
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of vilaprisan in Uterine Fibroids (UF) and endometriosis (4 arms), sponsored by Bayer. Primary endpoints: Hoogland score during treatment, Hoogland score during follow up and 1 more. Started Oct 2014; status: completed.
02
Drugs
vilaprisan
03
Conditions
Uterine Fibroids (UF)endometriosis
Beyond the preview
Go deeper on NCT02262663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02262663.